EMA regular press briefing on COVID-19

Date: 15/07/2021
Location: Virtual meeting

Event summary

The European Medicines Agency (EMA) is holding a press briefing to provide an update on its most recent activities in the context of the COVID-19 pandemic.


  • Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
  • Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
  • Georgy Genov (Head of Pharmacovigilance)

The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).

This is EMA’s last regular press briefing before the summer. EMA will resume the bi-weekly briefings in early September. EMA will also continue to organise ad-hoc press conferences as necessary and appropriate in the coming weeks.

The press briefing will be held in English. No translations will be provided.

Video recording


How useful was this page?

Add your rating
1 rating
8 ratings